Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2158-2165

  Kalled, Susan L ^a   Cutler, Anne H ^a   Datta, Syamal K ^b   Thomas, David W ^a  

^a BIOGEN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DISEASE SEVERITY; FIBROSIS; HAMSTER; IMMUNOTHERAPY; INCIDENCE; INFLAMMATION; KIDNEY FUNCTION; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL RATE; VASCULITIS;

AGE FACTORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; AUTOANTIBODIES; CD40 LIGAND; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; FEMALE; FIBROSIS; INFLAMMATION; KIDNEY; LIGANDS; LUPUS NEPHRITIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NZB; SPLEEN; SURVIVAL ANALYSIS; TIME FACTORS; VASCULITIS;

EID: 0032030667     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Boumpas, D. T., H. A. R. Austin, B. J. Fessler, J. E. Balow, J. H. Klippel, and M. D. Lockshin. 1995. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122:940.
2. Datta, S. K., H. Patel, and D. Berry. 1987. Induction of a cationic shift in IgG anti-DNA autoantibodies: role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165:1252.
3. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:103.
4. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
5. - T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB X SWR model of lupus nephritis. J. Immunol. 140:2215.
6. Adams, S., T. Zordan, K. Sainis, and S. Datta. 1990. T cell receptor V beta genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells. Eur. J. Immunol. 20:1435.
7. 1 murine SLE model. J. Immunol. 138:3185.
8. - T helper cell lines that express the gamma delta T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:7020.
9. Naiki, M., B. L. Chiang, D. Cawley, A. Ansari, S. J. Rozzo, B. L. Kotzin, A. Zlotnik, and M. E. Gershwin. 1992. Generation and characterization of cloned T helper cell lines for anti-DNA responses in NZB.H-2bm12 mice. J. Immunol. 149:4109.
10. Durie, F. H., T. M. Foy, S. R. Masters, J. D. Laman, and R. J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 15:406.
11. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328.
12. Gerritse, K., J. D. Laman, R. J. Noelle, A. Aruffo, J. A. Ledbetter, W. J. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93:2499.
13. Griggs, N. D., S. S. Agersborg, R. J. Noelle, J. A. Ledbetter, P. S. Linsley, and K. S. Tung. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183:801.
14. Durie, F. H., A. Aruffo, J. Ledbetter, K. M. Crassi, W. R. Green, L. D. Fast, and R. J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94:1333.
15. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J. Immunol. 158:29.
16. Mohan, C., Y. Shi, J. D. Laman, and S. K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470.
17. Early, G. S., W. Zhao, and C. M. Burns. 1996. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black X New Zealand white mice: response correlates with the absence of an anti-antibody response. J. Immunol. 157:3159.
18. Noelle, R. J., M. Roy, D. M. Shepherd, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550.
19. 1 hybrid mice: light and electron microscopic studies. Nephron 4:215.
20. Datta, S. K., P. J. McConahey, N. Manny, A. N. Theofilopoulos, F. J. Dixon, and R. S. Schwartz. 1978. Genetic studies of autoimmunity and retrovirus expression in crosses of New Zealand black mice. II. The viral envelope glycoprotein gp70. J. Exp. Med. 147:872.
21. Peto, R., M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. McPherson, J. Peto, and P. G. Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 35:1.
22. Strutz, F., and E. G. Neilson. 1994. The role of lymphocytes in the progression of interstitial disease. Kidney Int. 45(Suppl.):S106.
23. Okada, H., F. Strutz, T. M. Danoff, and E. G. Neilson. 1996. Possible pathogenesis of renal fibrosis. Kidney Int. 54(Suppl.):S37.
24. Eastcott, J. W., R. S. Schwartz, and S. K. Datta. 1983. Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB X SWR crosses. J. Immunol. 131:2232.
25. Lane, P., C. Burdet, F. McConnell, A. Lanzavecchia, and E. Padovan. 1995. CD40 ligand-independent B cell activation revealed by CD40 ligand-dencient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. Immunol. 25:1788.
26. Ma, J., J. Xu, M. P. Madaio, Q. Peng, J. Zhang, I. S. Grewal, R. A. Flavell, and J. Craft. 1996. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157: 417.
27. Desai-Mehta, A., L. Lu, R. Ramsey-Goldman, and S. K. Datta. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97:2063.
28. Koshy, M., D. Berger, and M. K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98:826.
29. Carbone, E., G. Ruggiero, G. Terrazzano, C. Palomba, C. Manzo, S. Fontana, H. Spits, K. Karre, and S. Zappacosta. 1997. A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185: 2053.
30. Mach, F., U. Schonbeck, G. K. Sukhova, T. Bourcier, J. Y. Bonnefoy, J. S. Pober, and P. Libby. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA 94:1931.
31. Hollenbaugh, D., N. Mischel-Petty, C. P. Edwards, J. C. Simon, R. W. Denfeld, P. A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33.
32. Yellin, M. J., J. Brett, D. Baum, A. Matsushima, M. Szabolcs, D. Stern, and L. Chess. 1995. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 182:1857.
33. Yellin, M. J., V. D' Agati, G. Parkinson, A. S. Han, A. Szema, D. Baum, D. Estes, M. Szabolcs, and L. Chess. 1997. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum. 40:124.
34. Alderson, M. R., R. J. Armitage, T. W. Tough, L. Strockbine, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 178: 669.
35. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
36. Yellin, M. J., S. Winikoff, S. M. Fortune, D. Baum, M. K. Crow, S. Lederman, and L. Chess. 1995. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukocyte Biol. 58:209.
37. Stout, R. D., J. Suttles, J. Xu, I. S. Grewal, and R. A. Flavell. 1996. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:8.
38. van Kooten, C., J. S. Gerritsma, M. E. Paape, L. A. van Es, J. Banchereau, and M. R. Daha. 1997. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int. 51:711.
39. Schall, T. J., K. Bacon, K. J. Toy, and D. V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347:669.
40. Seelen, M. A., R. A. Brooimans, F. J. van der Woude, L. A. van Es, and M. R. Daha. 1993. IFN-gamma mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int. 44:50.
41. Brooimans, R. A., A. P. Stegmann, W. T. van Dorp, A. A. van der Ark, F. J. van der Woude, L. A. van Es. and M. R. Daha. 1991. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J. Clin. Invest. 88:379.
42. Gerritsma, J. S., A. F. Gerritsen, M. De Ley, L. A. van Es, and M. R. Daha. 1997. Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 9:276.
43. Lloyd, C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells, D. J. Salant, and J. C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371.
44. Risdon, R. A., J. C. Sloper, and H. E. De Wardener. 1968. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet ii:363.
45. Bohle, A., M. Wehrmann, O. Bogenschutz, C. Batz, W. Vogl, H. Schmitt, C. A. Muller, and G. A. Muller. 1992. The long-term prognosis of the primary glomerulonephritides: a morphological and clinical analysis of 1747 cases. Pathol. Res. Pract. 188:908.
46. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693.
47. Kaliyaperumal, A., C. Mohan, W. Wu, and S. K. Datta. 1996. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183:2459.
48. Datta, S. K., A. Kaliyaperumal, and A. Desai-Mehta. 1997. T cells of lupus and molecular targets for immunotherapy. J. Clin. Immunol. 17:11.
49. 1 mice. J. Immunol. 158:1466.